Low testosterone
Low testosterone is a clinical syndrome in men, not just a lab value, and it requires persistent symptoms plus consistently low testosterone on proper morning testing. This hub explains what low testosterone means, why it happens, how to test for it correctly, and how treatment decisions change once LH and FSH are measured.
Find the cause before treating it
Choose a lab panel and get a clinical review with clear next steps.
Start with your question
- I want to understand what low testosterone is and how common it is
- Show me the main causes, including primary, secondary, and functional hypogonadism
- Help me recognize the symptoms that matter most
- Show me how to test correctly and avoid misleading results
- I want to see how low testosterone connects to obesity, diabetes, mood, and bone health
- Help me rule out conditions that can look like low testosterone
- Show me the difference between Enclomiphene and testosterone replacement therapy
- I want to know what recovery, monitoring, and long term management look like
Key takeaways
- Low testosterone is not diagnosed by a number alone. It requires persistent symptoms plus biochemical evidence of testosterone deficiency.
- Free testosterone, measured by equilibrium dialysis with LC-MS/MS or calculated from total testosterone, SHBG and albumin, helps when an unusual SHBG level makes total testosterone misleading.
- LH and FSH must be measured with testosterone because high LH plus low testosterone suggests primary hypogonadism, while low or normal LH plus low testosterone suggests secondary hypogonadism.
- Testing should be done in the morning, from 07:00 to 11:00, and a low result should be confirmed on a repeat sample. LC-MS/MS for total testosterone and equilibrium dialysis for free testosterone are the most accurate methods.
- In healthy aging men, testosterone declines slowly. EMAS reported about a 0.4% yearly fall in total testosterone and a 1.3% yearly fall in free testosterone.
- In the European Male Ageing Study, 2.1% of men ages 40 to 79 met a strict definition of symptomatic hypogonadism. Estimates are higher when looser criteria are used.
- TRT suppresses gonadotropins and sperm production. Enclomiphene raised testosterone while keeping sperm counts in the normal range in short trials of men with secondary hypogonadism, so the LH result decides whether it is an option.
Overview and stats
Low testosterone means symptomatic male hypogonadism, not just a lab value that falls near the bottom of a reference range. What is low testosterone? The clinical definition most men (and many doctors) get wrong explains why symptoms and biochemistry both matter. For age based context, see Low testosterone by age: What’s normal at 20, 30, 40, 50, and beyond. That article separates normal aging from disease and explains why a sharp drop is usually driven by obesity, metabolic disease, medications, or other health problems rather than age alone.
Prevalence changes with the definition used. In the European Male Ageing Study (EMAS), published in The New England Journal of Medicine, 2.1% of men ages 40 to 79 met a strict definition that required three sexual symptoms plus low total and free testosterone, and longitudinal EMAS data suggest that healthy aging is associated with only a small yearly decline in testosterone. For population context and why more younger men are being evaluated, read How common is low testosterone, and why are rates rising in younger men?.
Causes and how it develops
Where low testosterone starts determines treatment. If LH is high and testosterone is low, the testes are failing to respond and the pattern is primary hypogonadism. If LH is low or normal and testosterone is low, the problem is central. That points to secondary hypogonadism, where treatment that preserves fertility may be possible. Primary vs secondary hypogonadism: where the problem starts and why it changes everything shows why two men with the same testosterone result may need completely different care.
How the HPG axis works: the brain testes connection explained walks through GnRH, LH, FSH, testicular testosterone production, and feedback regulation. According to the Endocrine Society guideline, medications, systemic illness, and obesity can suppress the axis and create a functional or secondary pattern. For the causes men miss most often, including opioids and lifestyle factors, read Medications, substances, and lifestyle factors that quietly kill your testosterone.
Signs and symptoms
The most specific symptom pattern is sexual: reduced libido, erectile dysfunction, and loss of morning erections. For a full symptom map, read Low testosterone symptoms: the complete list most men don’t recognize. It separates sexual symptoms, which are the most specific, from physical symptoms such as lower activity tolerance and decreased mobility, and from psychological symptoms such as low motivation, fatigue, and low mood.
According to the EMAS study published in The New England Journal of Medicine, poor morning erections, low sexual desire, and erectile dysfunction were the symptoms most consistently linked to low testosterone in men ages 40 to 79. The authors proposed defining late onset hypogonadism as those three symptoms together with total testosterone below 11 nmol/L (about 320 ng/dL) and free testosterone below 220 pmol/L (about 64 pg/mL). Symptoms in a man in his twenties may look different from symptoms in a man in his sixties, and congenital or pubertal onset has a very different clinical picture. How low testosterone symptoms show up differently at every age explains those differences.
Testing and diagnosis
Diagnosis starts with symptoms and a morning blood draw from 07:00 to 11:00 that includes total testosterone, free testosterone, LH, and FSH. If testosterone is low or borderline, repeat morning testing is usually needed to confirm hypogonadism before treatment decisions are made. The complete low testosterone testing guide: what to order, when to test, and how to read results covers when not to test, why acute illness can temporarily lower testosterone, and why obesity, diabetes, medications, and treatment contraindications should be reviewed before results are interpreted.
How the sample is taken and measured affects the result. According to the EAU guideline, diagnosis should rely on reliable morning testing, and the Endocrine Society also emphasizes confirmation and careful evaluation. Free testosterone measured by equilibrium dialysis is the reference method, and a value calculated from total testosterone, SHBG, and albumin is an accepted alternative. Why your testosterone test came back “normal” and why that might be wrong explains common failures, including broad lab ranges, afternoon testing, and hidden deficiency in men with high SHBG.
Can you have low testosterone with normal FSH and LH?
Yes. A testosterone result below range with LH and FSH in the normal range usually points to the pituitary gland or hypothalamus rather than the testes. LH is the pituitary hormone that tells the Leydig cells to make testosterone, so when testosterone is low, a normal LH is inappropriately normal. When the testes themselves fail, as in Klinefelter syndrome, the pituitary typically drives LH and FSH up instead. The AUA guideline recommends measuring LH in every man with low testosterone, and measuring prolactin when LH is low or low normal, because a prolactin secreting pituitary tumor can suppress LH. Iron overload, pituitary disease, obesity and some medications belong in the same workup. Primary vs secondary hypogonadism and how the HPG axis works explain the pattern in full.
Related conditions
Obesity, metabolic syndrome, and type 2 diabetes are among the strongest clinical contexts for low testosterone. These conditions do not just coexist with hypogonadism. They can help drive it, and low testosterone can then worsen body composition, insulin resistance, and physical function. Obesity, metabolic syndrome, and type 2 diabetes: the low testosterone triangle explains this loop and why visceral fat is especially relevant. Functional hypogonadism linked to these conditions is the most common form in real world practice.
Low testosterone is also linked to mood symptoms, lower quality of life, and bone health concerns, although association is not the same as proof of cause. According to the EAU guideline, depressive symptoms and reduced quality of life are commonly reported in hypogonadal men, but the relationship is complex. Depression, bone loss, and other conditions linked to low testosterone covers what is established, what remains uncertain, and why testosterone therapy should not be framed as a treatment for type 2 diabetes itself.
Similar conditions to exclude
Fatigue, low mood, weight change, poor concentration, and sexual dysfunction can come from many conditions besides hypogonadism, so the diagnosis depends on both finding low testosterone and excluding other causes. It might not be low testosterone: conditions that mimic the same symptoms reviews the overlap with thyroid disorders, depression, anxiety, sleep problems, medication effects, and other causes of low energy or sexual symptoms. A single “normal” or “low” testosterone result without that review can miss the real cause.
Functional hypogonadism is common, potentially reversible, and easy to misclassify. According to the EAU guideline, obesity and chronic disease can suppress an otherwise intact axis, which means the testes may still respond if signaling is restored. Functional vs organic hypogonadism: is your low T reversible? explains how clinicians distinguish structural disease from reversible suppression and why that distinction changes prognosis, fertility planning, and treatment choice.
Treatment options
Treatment should follow the diagnosis, and the LH result is central to it. Enclomiphene blocks estrogen feedback at the hypothalamus, which increases GnRH and LH and stimulates the testes to make more of their own testosterone. Because the testes keep receiving their signal, it can preserve spermatogenesis and testicular function instead of suppressing them. It only works when the testes can respond, so it is not an option in primary hypogonadism. Alternatives to TRT: Enclomiphene, hCG, lifestyle, and fertility preserving options compares these approaches.
Testosterone replacement therapy is the established treatment for primary hypogonadism, but it is not the right first step for every man. The AUA guideline advises against prescribing it to men who are currently trying to conceive. Testosterone replacement therapy: formulations, dosing, and what to expect covers the major formulations. According to the TRAVERSE trial, TRT was noninferior to placebo for major cardiovascular events in 5,246 men followed for a mean of 33 months, although atrial fibrillation, acute kidney injury, and pulmonary embolism were more frequent in the testosterone group. A rise in hematocrit is a recognized effect of TRT, and the Endocrine Society guideline calls for checking it at baseline and during the first year of treatment.
Can low testosterone be treated without injections?
Yes, for many men with secondary hypogonadism. Injections and gels replace testosterone from outside, which lowers LH and FSH and, with them, sperm production. An oral medicine such as enclomiphene works the other way. It raises LH and FSH so the testes make more of their own testosterone.
In two randomized, double-blind phase III trials in overweight men aged 18 to 60 with secondary hypogonadism, 16 weeks of daily oral enclomiphene raised total testosterone, LH and FSH and kept sperm concentration in the normal range, while testosterone gel raised testosterone but lowered LH and FSH and markedly reduced sperm production (Kim et al., BJU International, 2016). These trials measured hormone levels and sperm counts over a few months, not long term outcomes.
That route fits only when LH and FSH show the problem starts in the signal from the brain, and after causes such as excess weight or medications have been reviewed. A morning panel with total and free testosterone, LH and FSH answers both questions, so a lab panel is the usual starting point.
Recovery and outlook
Hormone levels can begin changing within weeks, but symptom improvement usually unfolds over 4 to 12 weeks and body composition changes take longer. What to expect after starting treatment: realistic timelines and monitoring sets expectations for sexual symptoms, mood, energy, and physical changes, and explains why follow up labs are part of treatment rather than an option.
Long term outlook depends on the type of hypogonadism and whether the driver is reversible. Living with low testosterone: long term management and outcomes focuses on what happens after the initial response, including how comorbidities, medication changes, weight trends, and fertility plans influence treatment length. According to the Endocrine Society, testosterone therapy is for men with symptoms and consistently low testosterone, and the guideline advises against routinely treating older men only because their levels are low. In functional hypogonadism, some men can eventually reduce or stop treatment once the underlying suppression improves, which is why reassessment continues over time.
Frequently asked questions
- What actually counts as low testosterone?
- Low testosterone means symptomatic male hypogonadism. In practice, that requires persistent symptoms plus biochemical evidence of deficiency on proper morning testing. Exact cut-offs differ between guidelines and studies. EMAS, for example, used total testosterone below about 320 ng/dL and free testosterone below about 64 pg/mL together with three sexual symptoms.
- Is low testosterone just a normal part of getting older?
- No. Healthy aging is associated with a relatively small yearly decline in testosterone, not a sudden collapse. When levels fall more sharply, clinicians should look for obesity, type 2 diabetes, medication effects, sleep problems, chronic disease, or another cause of functional or organic hypogonadism.
- Why do LH and FSH matter so much?
- LH and FSH show where the problem starts. High LH with low testosterone points to primary hypogonadism, where the testes are not responding well. Low or normal LH with low testosterone points to secondary hypogonadism, where the brain is not sending a strong enough signal, and that distinction directly changes treatment and fertility implications.
- Can you have low testosterone symptoms even if your lab report says “normal”?
- Yes. A “normal” result may be misleading if the sample was drawn in the afternoon, if only total testosterone was checked, or if free testosterone was not measured accurately. Broad reference ranges can also hide clinically meaningful deficiency in younger or symptomatic men.
- Is functional hypogonadism reversible?
- Often, yes. Functional hypogonadism means the HPG axis is suppressed rather than structurally damaged, usually by obesity, metabolic disease, medications, or systemic illness. Some men improve when those drivers are treated, and Enclomiphene can raise natural testosterone production while the underlying issues are addressed.
- Will testosterone replacement therapy affect fertility?
- Yes. TRT suppresses gonadotropins and can reduce or stop sperm production, which is why it is a poor fit for men who want to preserve fertility. Enclomiphene raises testosterone while keeping the axis active, which is why it is considered in secondary and functional hypogonadism.
- How long does it take to feel better after treatment starts?
- Lab changes can appear early, but symptom relief is usually not immediate. Men may notice sexual or energy improvements within several weeks to a few months, while body composition and longer term physical changes usually take more time. Follow up testing lets treatment be adjusted based on both symptoms and objective results.
What to do about it
If symptoms suggest low testosterone, the next step is a morning blood test that includes total testosterone, free testosterone, LH, and FSH, repeated to confirm a low result. A list of current medications and any recent illness helps, since both can lower testosterone temporarily.
Veedma’s licensed providers order testing across the U.S. that includes total and free testosterone measured by LC-MS/MS with LH and FSH, or review labs a man already has. In Veedma’s protocol, treatment is considered when free testosterone is below 100 pg/mL with persistent symptoms, using enclomiphene or the enclomiphene plus tadalafil tablet when appropriate. Enclomiphene is not an FDA-approved drug; it is prescribed after a provider confirms the diagnosis and is compounded by a licensed U.S. pharmacy.
How we write and review this content
This hub is developed by Veedma’s editorial team using AI assisted research tools, under clinical rules set by Vladimir Kotlov, MD, urologist and founder of Veedma, and checked by automated validators before publication. The evidence base for this page includes guidance from the EAU, AUA, and Endocrine Society, observational data from EMAS, and relevant randomized trials such as TRAVERSE. Our goal is to separate diagnosis from hype so men can understand what low testosterone is, what it is not, and how a proper evaluation should work.
This content is educational and does not diagnose or treat any individual. It is designed to help readers understand testing, symptoms, causes, and treatment pathways so they can have better conversations with licensed providers. Read our full editorial policy.
Low energy, low libido, or brain fog?
Order your lab panelStart with a lab panel
Get a clinical review of your results and health history, with an explanation of the decision and next steps in your patient chat. If you are eligible and want treatment, choose a plan and save a card to book a video visit at no extra visit fee. Treatment billing starts only if prescribed.
Order your lab panelPrefer short video breakdowns? Follow @veedma.men on TikTok for quick, study-backed men's hormone explainers.

Vladimir Kotlov, MD: Founder & CEO at Veedma
Vladimir Kotlov, MD is the founder of Veedma. A urologist by training, he led a urology department at a fertility and reproductive clinic where he managed a team of 30+ clinicians and improved IVF outcomes by 24%. He then moved to Silicon Valley and spent five years advising healthtech companies before founding Veedma to help men access evidence-based hormone optimization and fertility care.